1994
DOI: 10.3109/02841869409098383
|View full text |Cite
|
Sign up to set email alerts
|

Primary Osteosarcoma of the Breast—Case Report and Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 11 publications
(4 reference statements)
0
17
0
Order By: Relevance
“…The value of axillary lymph node resection is not clearly defined, since osteogenic sarcomas rarely cause lymph node metas tases. However, in addition to our patient two further cases of osteogenic sarcomas of the breast with lymph node metastases were reported, and in addition four of six patients with pri mary exogenous osteosarcoma of the thoracic wall also had positive axillary lymph nodes [6,13,15]. Whether the lymphat ic nodes were involved by direct spread of the tumour or by lymphatic metastases in the latter cases cannot be clearly sepa rated.…”
Section: Discussion and Review Of The Literaturementioning
confidence: 81%
See 3 more Smart Citations
“…The value of axillary lymph node resection is not clearly defined, since osteogenic sarcomas rarely cause lymph node metas tases. However, in addition to our patient two further cases of osteogenic sarcomas of the breast with lymph node metastases were reported, and in addition four of six patients with pri mary exogenous osteosarcoma of the thoracic wall also had positive axillary lymph nodes [6,13,15]. Whether the lymphat ic nodes were involved by direct spread of the tumour or by lymphatic metastases in the latter cases cannot be clearly sepa rated.…”
Section: Discussion and Review Of The Literaturementioning
confidence: 81%
“…In addi tion all 4 patients treated with postoperative radiation therapy died of progressive disease [27,30,33,34]. Six patients in cluding our own had received combination chemotherapy [15,28,29,32,36]. The median survival of these patients was 30 months, and 2 patients have been long-term disease-free survivors after treatment with high-dose methotrexate, bleomycin, cyclophosphamide, DTIC and adriamycin in one case and with cisplatin, adriamycin and ifosfamide in the other [36,37].…”
Section: Discussion and Review Of The Literaturementioning
confidence: 99%
See 2 more Smart Citations
“…Applying this option is not standard treatment for the management of breast OS patients due to the limited number of clinical trials where polychemotherapy has been used in cases of this extremely rare tumour (1,46,11–15). In a situation where tumour-free surgical margins cannot be obtained, postoperative radiotherapy is sometimes advisable (4,5,8,1920). …”
Section: Discussionmentioning
confidence: 99%